| BBB | Blood–brain barrier |
| BTK | Bruton’s tyrosine kinase |
| BL | Burkitt’s Lymphoma |
| CLL | Chronic lymphocytic leukaemia |
| CLL-IPI | CLL-international prognostic index |
| COSY | Correlated spectroscopy |
| DEPT | Distortionless enhancement by polarisation transfer |
| D-MEM | Dulbecco’s modified Eagle’s medium |
| DMSO | Dimethylsulfoxide |
| EBV | Epstein–Barr virus |
| ECACC | European Collection of Animal Cell Cultures |
| ER | Estrogen receptor |
| FACS | Fluorescence-activated cell sorting |
| FBS | Foetal bovine serum |
| FDA | The United States Food and Drug Administration |
| FITC | Fluorescein isothiocyanate |
| HEPES | N-2-Hydroxyethylpiperazine-N′-2-ethanesulfonic acid |
| HER2 | Human epidermal growth factor receptor 2 |
| HRMS | High-resolution mass spectrometry |
| IC50 | Half-maximal inhibitory concentration |
| IGVH | Immunoglobulin heavy-chain gene |
| IR | Infrared |
| MEM | Eagle’s minimum essential medium |
| 4-MTA | 4-Methylthioamphetamine |
| NHL | Non-Hodgkin’s lymphoma |
| NMR | Nuclear magnetic resonance |
| PBMCs | Peripheral blood mononuclear cells |
| PI | Propidium iodide |
| PR | Progesterone receptor |
| RPMI 1640 | Roswell Park Memorial Institute 1640 medium |
| RT | Richter’s transformation |
| SERT | Serotonin transporter |
| TBNC | Triple-negative breast cancers |
| TPSA | Topological polar surface area |